964
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1

, , & ORCID Icon
Pages 4911-4922 | Received 23 Sep 2021, Accepted 29 Jan 2022, Published online: 12 Feb 2022

References

  • Byrd JK, Clair JM-S, El-Sayed I. AHNS series: do you know your guidelines? Principles for treatment of cancer of the paranasal sinuses: a review of the national comprehensive cancer network guidelines. Head Neck. 2018;40(9):1889–1896.
  • Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34(2):270–281.
  • Petersen JF, Timmermans AJ, van Dijk BA, et al. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Europ Archiv Oto-Rhino-Laryngol. 2018;275(1):181–189.
  • He X, Fang J, Chen X, et al. Actinidia chinensis Planch.: a review of chemistry and pharmacology. Front Pharmacol. 2019;10(1236). DOI:10.3389/fphar.2019.01236.
  • Wen-Jun Z, De-Hong Y, Mei Z, et al. Antiangiogenic triterpenes isolated from Chinese herbal medicine Actinidia chinensis Planch. Anticancer Agents Med Chem. 2013;13(2):195–198.
  • Gao Z, Deng G, Li Y, et al. Actinidia chinensis Planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression. Biomed Pharmacother. 2020;126:110092.
  • Wang L, Hou J, Wang J, et al. Regulatory roles of HSPA6 in Actinidia chinensis Planch. root extract (acRoots)-inhibited lung cancer proliferation. Clin Transl Med. 2020;10(2):e46.
  • Fang T, Fang Y, Xu X, et al. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition. J Ethnopharmacol. 2019;231:474–485.
  • O OZ, Yy Y, Y J, et al. The progress of chemical constituents isolated from the root of Actinidia chinensis Planch and their biological activities. J Biomed Res Rev. 2019;2(2):12–21.
  • Ana Filipa B, Marina R, Ana Margarida A, et al. Quercetin in cancer treatment, alone or in combination with conventional therapeutics?. Curr Med Chem. 2015;22(26):3025–3039.
  • Hou H, Li D, Cheng D, et al. Cellular redox status regulates emodin-induced radiosensitization of nasopharyngeal carcinoma cells in vitro and in vivo. J Pharm (Cairo). 2013;2013:218297.
  • Lee T-J, Kim OH, Kim YH, et al. Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2006;240(2):234–242.
  • Xu K, Al-ani MK, Wang C, et al. Emodin as a selective proliferative inhibitor of vascular smooth muscle cells versus endothelial cells suppress arterial intima formation. Life Sci. 2018;207:9–14.
  • Liu P, Zhang X, Li Z, et al. A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2020;524(4):816–824.
  • Wang Z, Wei P, Wei D, et al. Effect of up‐regulation of circMATR3 on the proliferation, metastasis, progression and survival of hypopharyngeal carcinoma. J Cell Mol Med. 2020;24(8):4687–4697.
  • Vageli DP, Doukas SG, Sasaki CT. Inhibition of NF-κB prevents the acidic bile-induced oncogenic mRNA phenotype, in human hypopharyngeal cells. Oncotarget. 2018;9(5):5876.
  • Huang Y, Zhu H, Ji X, et al. TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis. Oncol Lett. 2020;19(1):113–120.
  • Mu Y, Sa N, Yu L, et al. Epithelial cell adhesion molecule is overexpressed in hypopharyngeal carcinoma and suppresses the metastasis and proliferation of the disease when downregulated. Oncol Lett. 2014;8(1):175–182.
  • Guo R, Zou B, Liang Y, et al. LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma. Cell Death Dis. 2021;12(7):1–14.
  • Zhang K, Xiao M, and Jin X, et al. NR5A2 is one of 12 transcription factors predicting prognosis in HNSCC and regulates cancer cell proliferation in a p53-dependent manner. Front Oncol. 2021;11:2567.
  • Wang C, Shao S, Deng L, et al. LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway. Cancer Cell Int. 2020;20(1):1–12.
  • Qi F, Zhao L, Zhou A, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends. 2015;9(1):16–34.
  • Mou S, Zhou Z, He Y, et al. Curcumin inhibits cell proliferation and promotes apoptosis of laryngeal cancer cells through Bcl-2 and PI3K/Akt, and by upregulating miR-15a. Oncol Lett. 2017;14(4):4937–4942.
  • Hoffman RD, Li C-Y, He K, et al. Chinese herbal medicine and its regulatory effects on tumor related T cells. Front Pharmacol. 2020;11:492.
  • Gao L, Wang X-D, Niu -Y-Y, et al. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci Rep. 2016;6:24944.
  • Zhao Y, Liu Y. A mechanistic overview of herbal medicine and botanical compounds to target transcriptional factors in Breast cancer. Pharmacol Res. 2018;130:292–302.
  • Fang T, Hou J, He M, et al. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression. Cell Biol Toxicol. 2016;32(6):499–511.
  • Fang T, Zhao Z, Yuan F, et al. Actinidia chinensis Planch root extract attenuates proliferation and metastasis of hepatocellular carcinoma by inhibiting the DLX2/TARBP2/JNK/AKT pathway. J Ethnopharmacol. 2020;251:112529.
  • Ye Y, Gu B, Wang Y, et al. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma. J Cell Biochem. 2019;120(4):6145–6153.
  • Cheng Y, Pan Y, Pan Y, et al. MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer. Cancer Manag Res. 2019;11:803–812.
  • Chu J, Li H, Xing Y, et al. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. Biomed Pharmacother. 2019;116:109029.
  • Wang J, Xing H, Nikzad AA, et al. Long noncoding RNA MNX1 antisense RNA 1 exerts oncogenic functions in bladder cancer by regulating miR-218-5p/RAB1A axis. J Pharmacol Exp Ther. 2020;372(3):237.
  • Liu X, Yang Q, Yan J, et al. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. J Cell Biochem. 2019;120(3):4268–4277.
  • Li F, Chen Q, Xue H, et al. LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1/Hippo axis. Cell Death Dis. 2020;11(10):894.
  • Lv Y, Li H, Li F, et al. Long noncoding RNA MNX1-AS1 knockdown inhibits cell proliferation and migration in ovarian cancer. Cancer Biother Radiopharm. 2017;32(3):91–99.
  • Ma B, Ren G, Xu J, et al. LncRNA MNX1-AS1 contributes to laryngeal squamous cell carcinoma growth and migration by regulating mir-744-5p/bcl9/β-Catenin axis. Cell Transplant. 2021;30:096368972110056.